VAT/1szt.(0,77 / pc
Inflammatory Bowel Disease: Being studied for Crohns disease and ulcerative colitis due to its healing and anti-inflammatory properties
doi: 10.3389/fphar.2022.856111 Received 16 January 2022 Accepted 15 February 2022 Published 08 March 2022 Volume 13 - 2022 Edited by Giuseppe Paolisso, University of Campania Luigi Vanvitelli, Italy Reviewed by Stefano Ciardullo, University of Milano Bicocca, Italy Maria Rosaria Rizzo, University of Campania Luigi Vanvitelli, Italy Updates Copyright 2022 Pahud de Mortanges, Sinaci, Salvador, Bally, Muka, Wilhelm and Bano
Scientists are increasingly discovering the microbiome plays a powerful role in appetite regulation, including how much GLP-1 your body produces
We found that 17.7% of these patients regained all the weight they had lost or even exceeded their initial weight
EXAMINE, Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care